{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:28:25Z","timestamp":1793662105924,"version":"4.5.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.idcr.2023.e01703","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T13:03:01Z","timestamp":1674219781000},"page":"e01703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Omadacycline for the treatment of Mycobacterium abscessus infections: Case series and review of the literature"],"prefix":"10.1016","volume":"31","author":[{"given":"Ayesha","family":"Siddiqa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanza","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George D.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorana","family":"Segal-Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Turett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2023.e01703_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.659997","article-title":"Mycobacterium abscessus complex: a review of recent developments in an emerging pathogen","volume":"11","author":"Victoria","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.idcr.2023.e01703_bib2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3201\/eid2203.150828","article-title":"M. abscessus study team: treatment of Mycobacterium abscessus infection","volume":"22","author":"Novosad","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idcr.2023.e01703_bib3","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3389\/fmicb.2019.01977","article-title":"Clinical efficacy and adverse effects of antibiotics used to treat Mycobacterium abscessus pulmonary disease","volume":"10","author":"Chen","year":"2019","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.idcr.2023.e01703_bib4","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1056\/NEJMoa1800170","article-title":"Omadacycline for acute bacterial skin and skin-structure infections","volume":"380","author":"O'Riordan","year":"2019","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.idcr.2023.e01703_bib5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/cid\/ciz394","article-title":"Omadacycline: a modernized tetracycline","volume":"69","author":"Gallagher","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idcr.2023.e01703_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofaa415","article-title":"Omadacycline for the treatment of Mycobacterium abscessus Disease: a case series","volume":"7","author":"Pearson","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.idcr.2023.e01703_bib7","first-page":"e:5112:1","article-title":"Utilizing the promise of omadacycline in a resistant, non-tubercular mycobacterial pulmonary infection","volume":"11","author":"Minhas","year":"2019","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.idcr.2023.e01703_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofab002","article-title":"Preliminary, real-world, multicenter experience with omadacycline for Mycobacterium abscessus infections","volume":"8","author":"Morrisette","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.idcr.2023.e01703_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5021\/ad.2009.21.1.84","article-title":"A case of skin and soft tissue infection caused by Mycobacterium abscessus","volume":"21","author":"Kwon","year":"2009","journal-title":"Ann Dermatol"},{"issue":"1","key":"10.1016\/j.idcr.2023.e01703_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.idcr.2023.e01703_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/ijmr.IJMR_902_20","article-title":"Epidemiology, diagnosis and treatment of non-tuberculous mycobacterial disease","volume":"152","author":"Sharma","year":"2020","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.idcr.2023.e01703_bib12","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jac\/dkr578","article-title":"Mycobacterium abscessus: a new antibiotic nightmare","volume":"67","author":"Nessar","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.idcr.2023.e01703_bib13","first-page":"e01225","article-title":"Bedaquiline inhibits the ATP synthase in Mycobacterium abscessus and is effective in infected zebrafish","volume":"64","author":"Dupont","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.idcr.2023.e01703_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00827-19","article-title":"Bedaquiline eliminates bactericidal activity of \u03b2-lactams against Mycobacterium abscessus","volume":"63","author":"Lindman","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idcr.2023.e01703_bib15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/jac\/dkz511","article-title":"Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?","volume":"75","author":"Ruth","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.idcr.2023.e01703_bib16","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1093\/jac\/dkz267","article-title":"Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus","volume":"74","author":"Bax","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idcr.2023.e01703_bib17","doi-asserted-by":"crossref","first-page":"e00470","DOI":"10.1128\/AAC.00470-19","article-title":"In vitro activity of new tetracycline analogs omadacycline and eravacycline against drug-resistant clinical isolates of Mycobacterium abscessus","volume":"63","author":"Kaushik","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idcr.2023.e01703_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02522-18","article-title":"In vitro activities of omadacycline against rapidly growing mycobacteria","volume":"63","author":"Shoen","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idcr.2023.e01703_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.790767","article-title":"Omadacycline potentiates clarithromycin activity against Mycobacterium abscessus","volume":"12","author":"Bich Hanh","year":"2021","journal-title":"Front Pharm"},{"issue":"6","key":"10.1016\/j.idcr.2023.e01703_bib20","first-page":"e01704","article-title":"Potency of omadacycline against Mycobacterium abscessus clinical isolates in vitro and in a mouse model of pulmonary infection","volume":"66","author":"Nicklas","year":"2022","journal-title":"Antimicrob Agents Chemother"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250923000276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250923000276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:06:27Z","timestamp":1761998787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250923000276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":20,"alternative-id":["S2214250923000276"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2023.e01703","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omadacycline for the treatment of Mycobacterium abscessus infections: Case series and review of the literature","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2023.e01703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e01703"}}